ES2425298B1 - PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF METALASIS - Google Patents
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF METALASIS Download PDFInfo
- Publication number
- ES2425298B1 ES2425298B1 ES201230195A ES201230195A ES2425298B1 ES 2425298 B1 ES2425298 B1 ES 2425298B1 ES 201230195 A ES201230195 A ES 201230195A ES 201230195 A ES201230195 A ES 201230195A ES 2425298 B1 ES2425298 B1 ES 2425298B1
- Authority
- ES
- Spain
- Prior art keywords
- treatment
- pharmaceutical compositions
- metalasis
- mannoprotein
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Composiciones farmacéuticas para el tratamiento de la metástasis.#La presente invención se relaciona con el empleo de un compuesto con capacidad de unión a una manoproteína y bloquear la unión de dicha manoproteína a un receptor de las células endoteliales, en la elaboración de una composición farmacéutica para el tratamiento de una enfermedad asociada a una adhesión celular indeseada. Asimismo, la presente invención también contempla métodos dirigidos a identificar un compuesto potencialmente útil para la prevención y/o el tratamiento de una enfermedad asociada a una adhesión celular indeseada, a pronosticar la probabilidad de un paciente que padece cáncer a sufrir metástasis y a diseñar una terapia personalizada a un paciente que padece cáncer.Pharmaceutical compositions for the treatment of metastasis. # The present invention relates to the use of a compound capable of binding to a mannoprotein and blocking the binding of said mannoprotein to a receptor of endothelial cells, in the preparation of a pharmaceutical composition for the treatment of a disease associated with unwanted cell adhesion. Likewise, the present invention also contemplates methods aimed at identifying a compound potentially useful for the prevention and / or treatment of a disease associated with unwanted cell adhesion, to predict the probability of a patient suffering from cancer to metastasize and to design a therapy. personalized to a patient suffering from cancer.
Description
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201230195A ES2425298B1 (en) | 2009-04-02 | 2009-04-02 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF METALASIS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201230195A ES2425298B1 (en) | 2009-04-02 | 2009-04-02 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF METALASIS |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| ES2425298A2 ES2425298A2 (en) | 2013-10-14 |
| ES2425298R1 ES2425298R1 (en) | 2013-11-08 |
| ES2425298B1 true ES2425298B1 (en) | 2014-10-01 |
Family
ID=49231804
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES201230195A Active ES2425298B1 (en) | 2009-04-02 | 2009-04-02 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF METALASIS |
Country Status (1)
| Country | Link |
|---|---|
| ES (1) | ES2425298B1 (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050153361A1 (en) * | 2003-09-09 | 2005-07-14 | Sullivan Dianne C. | Therapeutic and diagnostic applications of protein disulphide isomerases |
| AU2006235490A1 (en) * | 2005-04-12 | 2006-10-19 | Romark Laboratories, L.C. | Methods for treating diseases through the function of molecular chaperones such as protein disulfide isomerases, pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents |
-
2009
- 2009-04-02 ES ES201230195A patent/ES2425298B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2425298A2 (en) | 2013-10-14 |
| ES2425298R1 (en) | 2013-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL261348A (en) | An isolated antibody or fragment thereof that binds cd100, for use in the treatment of an autoimmune disease, an inflammatory disease of cancer | |
| CL2008001076A1 (en) | COMPOUNDS DERIVED FROM SULFONAMIDE; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF CANCER. | |
| CL2008001656A1 (en) | Anti-c3b antibody; pharmaceutical composition comprising it, and its use to prevent or treat a complement-associated disorder; kit containing it. | |
| GT200800250A (en) | ARILIMIDAZOLONAS AND ARILTRIAZOLONAS REPLACED AS INHIBITORS OF VASOPRESINE RECEPTORS | |
| CL2008003798A1 (en) | Compounds derived from substituted aromatic heterobicycles, py3 kinase inhibitors; pharmaceutical composition; Useful in the treatment of cancer, melanomas, glioblastomas, among other diseases. | |
| CL2008003116A1 (en) | Bicyclic heterocyclic compounds; pharmaceutical composition comprising said compounds; and its use in the treatment or prevention of diseases such as diabetes, obesity, metabolic disorder, cardiovascular disease among others. | |
| ECSP11011297A (en) | ILL-17 BINDING PROTEINS | |
| CL2009000402A1 (en) | Substituted 2-amino-acetamide derived compounds; pharmaceutical composition; Useful in the treatment of lung diseases, rheumatic disease, autoimmune disease, among others. | |
| CL2007002640A1 (en) | COMPOUNDS DERIVED FROM 3- (6-OXO-1,6-DIHIDRO-PIRIDIN-3-IL) -BENZAMIDA; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF CANCER. | |
| CL2007003341A1 (en) | COMPOUNDS DERIVED FROM IMIDAZOTRIAZINAS; PHARMACEUTICAL COMPOSITION, USEFUL FOR THE TREATMENT OF CANCER, ARTEROSCLEROSIS AND CARDIOVASCULAR DISEASES BETWEEN OTHERS. | |
| CL2007002642A1 (en) | COMPOUNDS DERIVED FROM 3- (6-OXO-1,6-DIHIDRO-PIRIDIN-3-IL) -BENZAMIDA; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF CANCER. | |
| WO2012006589A3 (en) | Methods and compositions for identification, assessment and treatment of cancers associated with hedgehog signaling | |
| CL2007003202A1 (en) | COMPOUNDS DERIVED FROM ESPIROINDOLINONA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF CELL PROLIFERATION DISORDERS. | |
| CL2007001724A1 (en) | USE OF A STROGEN FOR THE TREATMENT OF DISEASES, CONDITIONS OR SYMPTOMS ASSOCIATED WITH DEFICIENT LEVELS OF STROGENS IN A WOMAN; PHARMACEUTICAL COMPOSITION THAT INCLUDES DAILY DOSAGE UNITS OF ESTRADIOL HEMIDRATE> 0.75 AND 1 | |
| BRPI0819218A2 (en) | Methods, kits and compositions for administering pharmaceutical compounds | |
| AR054539A1 (en) | NEW ANTIBODIES ANTI- MADCAM | |
| IL193444A (en) | Isolated, cross-reactive monoclonal antibody that binds both il-17a and il-17f and isolated antisera containing it, a diagnostic kit comprising it, a pharmaceutical composition comprising it and uses thereof as a medicament for the treatment or prevention of inflammation or an inflammatory disease | |
| IL196470A (en) | Antagonist antibody for cancer treatment | |
| BRPI0822398A2 (en) | SOLID FORM, MIXTURE, PHARMACEUTICAL COMPOSITION, AND METHODS FOR TREATING OR PREVENTING A DISEASE OR DISORDER AND CANCER | |
| CL2007000161A1 (en) | COMPOUNDS DERIVED FROM SUBSTITUTED 2,4-DIOXOIMIDAZOLIDINE, INHIBITORS OF KINE PROTEINS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS CANCER. | |
| CL2008001994A1 (en) | COMPOUNDS DERIVED FROM PIRAZIN-2-ONA; PHARMACEUTICAL COMBINATION; AND USE IN THE TREATMENT OF DISEASES SUCH AS DIABETES, ATEROSCLEROSIS, HYPERTENSION, AMONG OTHERS. | |
| CL2008001304A1 (en) | COMPOUNDS DERIVED FROM REPLACED INDOL, INHIBITORS OF THE 5-LIPOXYGENASE ACTIVATING PROTEIN (FLAP); PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF SUCH DISEASES AS COPD, CARDIOVASCULAR DISEASE AND INFLAMMATION. | |
| CO6280490A2 (en) | 4- (4-CIANO-2-TIOARIL) DIHYDROPIRIMIDINONES AND ITS USE | |
| CL2008000022A1 (en) | COMPOUNDS DERIVED FROM PHENYL- (4-PHENYL PYRIMIDIN-2-IL) -AMINAS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; PROCEDURE FOR PREPARATION OF SUCH COMPOUNDS; AND ITS USE IN INFLAMMATORY DISEASES, DIABETES AND CANCER. | |
| CL2008002369A1 (en) | Compounds derived from pyridin-3-yl-oxypyridin-2-yl-amino, alk5 inhibitors; pharmaceutical composition comprising said compound; and use of the compound in the treatment of cancer. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 2425298 Country of ref document: ES Kind code of ref document: B1 Effective date: 20141001 |